RC88
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RC88, covering 2024-04-30 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]